Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Trial Population69mg/wk Population
Train Both Clinical and Non-Clinical Team Members Give injectors and clinical staff detailed protocol training, including screening and documentation
Over time, chronic inflammation can quietly affect nearly every system in the body contributing to fatigue, brain fog, hormone imbalance, weight gain, digestive issues, joint pain, accelerated aging, poor recovery, and increased risk for cardiovascular disease, autoimmune disorders, insulin resistance, and neurodegenerative disease
Clinical context and dosing Thymosin alpha-1 is approved in more than 35 countries for the treatment of hepatitis B and C, giving it a well-established safety record
The Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) estimates the global and regional burden of stroke during 19902010
US$ 22.10
US$ 26.30
US$ 24.44
US$ 22.63
US$ 21.54
US$ 28.21
US$ 27.05
US$ 24.87